265 related articles for article (PubMed ID: 3456268)
1. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA class II determinants by normal and chronic myeloid leukemia progenitors.
Piacibello W; Aglietta M; Stacchini A; Spinelli P; Salvetti L; Kerim S; Malavasi F; Infelise V; Resegotti L; Gavosto F
Leuk Res; 1987; 11(3):285-90. PubMed ID: 3470577
[TBL] [Abstract][Full Text] [Related]
3. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
Dowding CR; Gordon MY; Goldman JM
Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
[TBL] [Abstract][Full Text] [Related]
4. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
Kelley VE; Fiers W; Strom TB
J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
[TBL] [Abstract][Full Text] [Related]
5. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of class-II MHC antigens during hemopoietic differentiation.
Katz FE; Davis L; Myers CD; Greaves MF
Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
8. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
Linch DC; Nadler LM; Luther EA; Lipton JM
J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
[TBL] [Abstract][Full Text] [Related]
9. IL-4 and granulocyte-macrophage colony-stimulating factor selectively increase HLA-DR and HLA-DP antigens but not HLA-DQ antigens on human monocytes.
Gerrard TL; Dyer DR; Mostowski HS
J Immunol; 1990 Jun; 144(12):4670-4. PubMed ID: 2112573
[TBL] [Abstract][Full Text] [Related]
10. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
[TBL] [Abstract][Full Text] [Related]
11. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
Lu L; Pelus LM; Broxmeyer HE
Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
Greenberg P; Grossman M; Charron D; Levy R
Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
Ottmann OG; Nocka KH; Moore MA; Pelus LM
Leukemia; 1988 Oct; 2(10):677-86. PubMed ID: 3172844
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of HLA-class II antigens on peripheral blood monocytes from aged humans.
Villanueva JL; Solana R; Alonso MC; Peña J
Dis Markers; 1990; 8(2):85-91. PubMed ID: 2387126
[TBL] [Abstract][Full Text] [Related]
18. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
Falkenburg JH; Fibbe WE; Veenhof WF; Koning F; van Eeden G; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
[TBL] [Abstract][Full Text] [Related]
19. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
